← All claims

Metabolic & Cardiometabolic

ezetimibe decreases diabetes risk

Strong support Metabolic & Cardiometabolic πŸ”¬ Includes disconfirming

Part of: πŸ’Š ezetimibe

RefutedContestedStrong support
consensus score 0.76

πŸ“… Last reviewed: 2026-07-15 β“˜

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Human trials (RCT / n-of-1)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

2 support 0 contradict 1 tested null 1 mixed Β· 4 sources, 2 independent groups

What the evidence shows

Unlike high-intensity statins (which modestly raise new-onset diabetes risk), ezetimibe is glucose-NEUTRAL - no diabetogenic signal in IMPROVE-IT/RACING. Swapping some statin dose for ezetimibe may slightly reduce the regimen's glycemic burden. (Claim framed as 'does not increase diabetes risk'.)

The evidence (4)

SourceGradeStanceQualityFinding
Cannon CP, et al. (IMPROVE-IT)
2015 Β· N Engl J Med
RCT supports moderate [FT-verified] No increased incident diabetes with ezetimibe (vs statins' modest diabetogenic signal) β€” BUT glucose-neutrality was an unstated secondary outcome, inferred rather than a pre-specified endpoint. Quality downgraded from high on that basis. (Merged 2026-07-21 from two conflicting appraisals of the same source.)
Su PH et al
2026 Β· study_type: observational
observational tested-null low Retrospective cohort (propensity-matched, n=7676 per arm) comparing bempedoic acid vs ezetimibe initiators for hyperuricemia; longitudinal glycemic measures were 'generally similar between groups' over 12 months.
Barkas 2016
2016 Β· J Clin Lipidol
observational supports low [FT-verified] Barkas Greek n=877 ezetimibe add-on OR 0.89 incident DM vs high-intensity statin OR 2.12; supports neutrality
Perego 2019
2019 Β· BBA Mol Basis Dis
mechanism mixed low [FT-verified] Perego review ezetimibe acts on absorption not LDL-R; mechanistically non-diabetogenic

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

πŸ“š Suggest a study βš‘ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account β€” we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.